Current Size: 100%

Ludwig Boltzmann Institute for COPD And Respiratory Epidemiology

"Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown" has been published!

NEW! The results of our LEAD-COVID antibody study have been published in Scientific Reports.

World Asthma Day

On the occasion of World Asthma Day, our scientific director of the LEAD Study Robab Breyer-Kohansal explains which factors to look out for in children with regard to asthma.

An Interview about the LEAD-COVID-Antibody-Study

Marie-Kathrin Breyer, MD on the results of the LEAD-COVID antibody study in an interview.

(available in german)

►To the ORF-Article

We congratulate...

... our Postdoc Caspar Schiffers on the successful defence of his PhD thesis at the University of Maastricht!

Research saves lives

The Austrian LEAD Study is the world’s biggest study on COPD and examines the Austrian lung health with a long-term and holistic approach. We want to thank all our supporters and sponsors, without whose help the conduction of the study would be impossible. For the continued existence of the study, we also need your support!

Search form